Infectious burden and atherosclerosis: A clinical issue.
about
Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-AnalysisChlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategiesBiophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci.Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.Emerging risk biomarkers in cardiovascular diseases and disordersSeasonal Influenza Infections and Cardiovascular Disease Mortality.An Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis.Adiponectin abates atherosclerosis by reducing oxidative stressCitreoviridin Enhances Atherogenesis in Hypercholesterolemic ApoE-Deficient Mice via Upregulating Inflammation and Endothelial Dysfunction.Absence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay.Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study.Pseudomonas aeruginosa Microcolonies in Coronary Thrombi from Patients with ST-Segment Elevation Myocardial InfarctionAssociation between Bacterial Infection and Peripheral Vascular Disease: A ReviewAdiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice.Effects of Murine Norovirus on Chlamydia pneumoniae-Accelerated Atherosclerosis in ApoE(-/-) MiceBiophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment.Immunopathogenesis of Chlamydial Infections.Cardioprotective role of G-Protein Coupled Estrogen Receptor 1 (GPER1).Periodontal herpesviruses: prevalence, pathogenicity, systemic risk.Association Between Helicobacter Pylori Infection and Long-term Outcome in Patients with Drug-eluting Stent Implantation.Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.Pulse Wave Velocity in Kawasaki Disease.Detection of Fungal Elements in Atherosclerotic Plaques Using Mycological, Pathological and Molecular Methods.Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.Cohort profile: the Healthy Life in an Urban Setting (HELIUS) study in Amsterdam, The Netherlands.The Porphyromonas gingivalis/Host Interactome Shows Enrichment in GWASdb Genes Related to Alzheimer's Disease, Diabetes and Cardiovascular Diseases.Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1.Ethnic differences in infectious burden and the association with metabolic risk factors for cardiovascular disease: a cross-sectional analysis.Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week
P2860
Q26783046-A6F7DEE3-2256-4C02-968E-EDC564DEC1B4Q27009367-742192FF-90E7-4A68-B602-BDC12828B503Q27302171-198B081F-426E-444D-9408-0DCFBE134A72Q27333657-5E8A0BCA-A91A-4844-9FB1-FA53D514DE12Q28081614-B1085F2A-CD17-4D09-8642-27F3CA4BA0EBQ30390770-610201F9-75A4-4A60-BC79-40FD11307EE4Q33763278-AA23259E-A4FD-4507-88F9-06C96FAA27D4Q34338139-42773964-AC8D-47F7-82A6-8D7CD879CADAQ35560897-7480C540-DF9E-4891-9465-276EF9ACAA57Q35875899-87E48B52-BC0E-400A-8BB3-FBEC9B1F14BEQ35960698-60FF2685-F0A8-464A-AC21-0E3169E1E679Q36234857-795F6345-79FC-49CB-9C31-1DF71955DB3FQ36596797-27237C3E-A50E-42BB-A32E-6F4195B4EA4EQ36675844-9D6DA6D1-4887-48ED-88FE-B4AC817E1EBDQ37003254-A6A5F4BE-5FD1-4957-B167-FEABA27C9A58Q37835765-B18CAD1B-5252-4480-A7F1-07D35F9C64ACQ37836040-ADCEAE97-FB63-4B72-802E-09EA5EE0AF52Q38448584-42122296-B195-462D-BBD6-98D800A5CA19Q38562419-13268447-4E1E-41C0-B1BB-39030C50D87DQ38681372-C7E275DB-B692-4A43-9866-74967850DA96Q38781034-B84936A6-492F-476E-B807-79FF4EBF78E5Q38844430-AF5775EC-6362-4E60-8BF4-551DBE836483Q40298495-A4319913-AF91-49BA-B555-9E3687BA38F8Q46257956-947CA170-71B9-46D4-B72C-F577A2673562Q47134438-3F6D0071-D199-4AFB-875E-B8951D619ED6Q47194761-DB5A35BB-D340-4EB0-9EEB-964074085909Q48194500-A30CB1A8-B3E8-4E98-9EC0-853E1F9A48DBQ54268204-0EFD1E77-D868-41E3-8467-9050BDBA723EQ57797462-12210DB7-8590-422F-8F14-FD2129CC2F89
P2860
Infectious burden and atherosclerosis: A clinical issue.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infectious burden and atherosclerosis: A clinical issue.
@en
Infectious burden and atherosclerosis: A clinical issue.
@nl
type
label
Infectious burden and atherosclerosis: A clinical issue.
@en
Infectious burden and atherosclerosis: A clinical issue.
@nl
prefLabel
Infectious burden and atherosclerosis: A clinical issue.
@en
Infectious burden and atherosclerosis: A clinical issue.
@nl
P2093
P2860
P356
P1476
Infectious burden and atherosclerosis: A clinical issue
@en
P2093
Marisa Di Pietro
Ombretta Turriziani
Rosa Sessa
P2860
P304
P356
10.12998/WJCC.V2.I7.240
P577
2014-07-01T00:00:00Z